Shintaro Mandai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shintaro Mandai has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
Shinichi Uchida
27 shared publicationsFumiaki Ando
17 shared publicationsKoichiro Susa
17 shared publicationsSoichiro Iimori
17 shared publicationsTakayasu Mori
17 shared publicationsEisei Sohara
16 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Elsevier in Kidney Medicine
β-Lactams vs Fluoroquinolones for Empiric Treatment of Suspected Kidney Cyst Infection: A Nationwide Observational Study
- 23 October 2026
- Published by Elsevier in Kidney Medicine
Open Accessβ-Lactams vs Fluoroquinolones for Empiric Treatment of Suspected Kidney Cyst Infection: A Nationwide Observational Study
- Open Access
- 21 August 2026
- Published by Wolters Kluwer Health in Kidney360
Dietary Fiber Attenuates the Association between Protein Intake and BUN in Patients with CKD
Background: While greater protein intake may contribute to BUN levels in patients with CKD, few studies have investigated whether dietary fiber modifies the association. We aimed to examine the effect modification of the association between protein intake and BUN by dietary fiber in patients with non-dialysis-dependent CKD. Methods: We included 274 patients (median age 72 years; 34% women) at three hospitals in Japan. Food group and nutrient intakes were estimated using a validated diet history questionnaire. We compared food group intake by dietary fiber tertiles. Multiple linear regression assessed the association between protein intake and BUN, adjusting for potential confounders. We performed stratified analyses by dietary fiber tertiles and interaction analyses. Results: The median (interquartile range) BUN was 24 (19–37) mg/dL, and the mean (standard deviation (SD)) estimated glomerular filtration rate was 33 (16) mL/min/1.73m 2 . The mean (SD) protein and fiber intakes were 39 (8) and 6.5 (2.2) g/1000 kcal/day, respectively. Patients with higher fiber intake had greater intake of fruits, vegetables, fish, and eggs than those with lower fiber intake. Protein intake was positively associated with natural log-transformed BUN (regression coefficient (β) = 0.05, 95% CI: 0.01 to 0.08, for one SD increase in protein intake). The association appeared stronger in the low-fiber (β = 0.08, 95% CI: 0.02 to 0.14) and medium-fiber groups (β = 0.08, 95% CI: 0.02 to 0.13), whereas it was not significant in the high-fiber group (β = 0.01, 95% CI: -0.03 to 0.06) (P for interaction = 0.10). Conclusions: The positive association between protein intake and BUN was attenuated in patients with high fiber intake, who had higher intakes of fruits, vegetables, fish, and eggs. Further studies are warranted to examine whether more liberal protein restriction is feasible in BUN management by increasing dietary fiber.
- 21 August 2026
- Published by Wolters Kluwer Health in Kidney360
Open AccessDietary Fiber Attenuates the Association between Protein Intake and BUN in Patients with CKD
Background: While greater protein intake may contribute to BUN levels in patients with CKD, few studies have investigated whether dietary fiber modifies the association. We aimed to examine the effect modification of the association between protein intake and BUN by dietary fiber in patients with non-dialysis-dependent CKD. Methods: We included 274 patients (median age 72 years; 34% women) at three hospitals in Japan. Food group and nutrient intakes were estimated using a validated diet history questionnaire. We compared food group intake by dietary fiber tertiles. Multiple linear regression assessed the association between protein intake and BUN, adjusting for potential confounders. We performed stratified analyses by dietary fiber tertiles and interaction analyses. Results: The median (interquartile range) BUN was 24 (19–37) mg/dL, and the mean (standard deviation (SD)) estimated glomerular filtration rate was 33 (16) mL/min/1.73m 2 . The mean (SD) protein and fiber intakes were 39 (8) and 6.5 (2.2) g/1000 kcal/day, respectively. Patients with higher fiber intake had greater intake of fruits, vegetables, fish, and eggs than those with lower fiber intake. Protein intake was positively associated with natural log-transformed BUN (regression coefficient (β) = 0.05, 95% CI: 0.01 to 0.08, for one SD increase in protein intake). The association appeared stronger in the low-fiber (β = 0.08, 95% CI: 0.02 to 0.14) and medium-fiber groups (β = 0.08, 95% CI: 0.02 to 0.13), whereas it was not significant in the high-fiber group (β = 0.01, 95% CI: -0.03 to 0.06) (P for interaction = 0.10). Conclusions: The positive association between protein intake and BUN was attenuated in patients with high fiber intake, who had higher intakes of fruits, vegetables, fish, and eggs. Further studies are warranted to examine whether more liberal protein restriction is feasible in BUN management by increasing dietary fiber.
- Open Access
- 28 April 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (18)
LRBA organizes distinct vesicular trafficking systems in distal nephron segments for water and sodium conservation
Lipopolysaccharide-responsive and beige-like anchor protein (LRBA) deficiency is a rare genetic disorder characterized by immune dysregulation. The immune checkpoint molecule cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) fails to perform proper membrane trafficking in the absence of LRBA. In addition to immune cells, LRBA localizes to intracellular vesicles in various epithelial cells; however, its physiological roles have not been accurately deciphered. It was observed in this study that LRBA facilitates water and sodium transport by promoting vesicular trafficking of aquaporin-2 (AQP2) and AQP4 in renal collecting duct cells and that of sterile 20/SPS1-related proline/alanine-rich kinase (SPAK) in distal convoluted tubule cells. Consequently, Lrba knockout mice exhibited vasopressin-resistant polyuria and hypotension under sodium-restricted conditions. This registry study revealed a polyuric phenotype in a subset of patients with LRBA deficiency, characterized by inappropriately low urine specific gravity despite the presence of chronic diarrhea. Notably, desmopressin treatment ameliorated impaired urinary concentration in a mouse model of human LRBA deficiency. LRBA functions as a central coordinator of fluid and sodium homeostasis by organizing segment-specific vesicular trafficking systems in renal epithelial cells.
- 28 April 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (18)
Open AccessLRBA organizes distinct vesicular trafficking systems in distal nephron segments for water and sodium conservation
Lipopolysaccharide-responsive and beige-like anchor protein (LRBA) deficiency is a rare genetic disorder characterized by immune dysregulation. The immune checkpoint molecule cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) fails to perform proper membrane trafficking in the absence of LRBA. In addition to immune cells, LRBA localizes to intracellular vesicles in various epithelial cells; however, its physiological roles have not been accurately deciphered. It was observed in this study that LRBA facilitates water and sodium transport by promoting vesicular trafficking of aquaporin-2 (AQP2) and AQP4 in renal collecting duct cells and that of sterile 20/SPS1-related proline/alanine-rich kinase (SPAK) in distal convoluted tubule cells. Consequently, Lrba knockout mice exhibited vasopressin-resistant polyuria and hypotension under sodium-restricted conditions. This registry study revealed a polyuric phenotype in a subset of patients with LRBA deficiency, characterized by inappropriately low urine specific gravity despite the presence of chronic diarrhea. Notably, desmopressin treatment ameliorated impaired urinary concentration in a mouse model of human LRBA deficiency. LRBA functions as a central coordinator of fluid and sodium homeostasis by organizing segment-specific vesicular trafficking systems in renal epithelial cells.
- Top Cited PapersOpen Access
- 6 January 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (1) , e045148
Circulating Extracellular Vesicle MicroRNAs as Predictive Biomarkers for Kidney and Cardiovascular Events
Background: Chronic kidney disease ( CKD ) leads to premature mortality from cardiovascular events before kidney replacement therapy. Despite recognition of syndromes like cardiorenal anemia and cardiovascular‐kidney‐metabolic, predictive models for kidney and cardiovascular outcomes remain inadequate. This study aimed to develop a minimally invasive, risk model using circulating small extracellular vesicle‐derived mi RNAs among patients with CKD . Methods: A derivation cohort (n=36) underwent microarray‐based miRNA profiling, and a least absolute shrinkage and selection operator‐penalized Cox proportional hazards model was constructed. Validation was performed using TaqMan quantitative polymerase chain reaction in a cohort of 234 patients with CKD without kidney replacement therapy. The primary outcome was a ≥30% reduction in estimated glomerular filtration rate or progression to kidney replacement therapy. The secondary outcome included all‐cause mortality, kidney replacement therapy initiation, and major adverse cardiovascular events. Results: In the derivation cohort, 36% of patients had hypertensive glomerulosclerosis as the underlying CKD cause, increasing to 48% in the validation cohort. Twenty‐three miRNAs were significantly downregulated in advanced CKD , associated with cellular senescence, FOXO (forkhead box, class O) signaling, and cell cycle pathways. From these, 3 miRNAs — hsa‐let‐7d‐5p , hsa‐ miR ‐24‐3p , and hsa‐ miR ‐126‐3p —were selected and integrated into the final risk score with cystatin C and urinary protein levels, following optimization in the validation cohort. Lower miRNA levels were linked to cardiovascular comorbidities and cardiorenal anemia syndrome. Over a median follow‐up of 39 and 59 months, 108 kidney events and 70 composite outcomes occurred. The model effectively predicted adverse outcomes across CKD causes, further stratifying risk within cardiovascular‐kidney‐metabolic stage classifications. Conclusions: Circulating small extracellular vesicle‐derived miRNA profiles enable a noninvasive, longitudinally predictive model for adverse kidney and cardiovascular outcomes in CKD . This approach may improve early risk identification and clinical decision‐making.
- 6 January 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (1) , e045148
Top Cited PapersOpen AccessCirculating Extracellular Vesicle MicroRNAs as Predictive Biomarkers for Kidney and Cardiovascular Events
Background: Chronic kidney disease ( CKD ) leads to premature mortality from cardiovascular events before kidney replacement therapy. Despite recognition of syndromes like cardiorenal anemia and cardiovascular‐kidney‐metabolic, predictive models for kidney and cardiovascular outcomes remain inadequate. This study aimed to develop a minimally invasive, risk model using circulating small extracellular vesicle‐derived mi RNAs among patients with CKD . Methods: A derivation cohort (n=36) underwent microarray‐based miRNA profiling, and a least absolute shrinkage and selection operator‐penalized Cox proportional hazards model was constructed. Validation was performed using TaqMan quantitative polymerase chain reaction in a cohort of 234 patients with CKD without kidney replacement therapy. The primary outcome was a ≥30% reduction in estimated glomerular filtration rate or progression to kidney replacement therapy. The secondary outcome included all‐cause mortality, kidney replacement therapy initiation, and major adverse cardiovascular events. Results: In the derivation cohort, 36% of patients had hypertensive glomerulosclerosis as the underlying CKD cause, increasing to 48% in the validation cohort. Twenty‐three miRNAs were significantly downregulated in advanced CKD , associated with cellular senescence, FOXO (forkhead box, class O) signaling, and cell cycle pathways. From these, 3 miRNAs — hsa‐let‐7d‐5p , hsa‐ miR ‐24‐3p , and hsa‐ miR ‐126‐3p —were selected and integrated into the final risk score with cystatin C and urinary protein levels, following optimization in the validation cohort. Lower miRNA levels were linked to cardiovascular comorbidities and cardiorenal anemia syndrome. Over a median follow‐up of 39 and 59 months, 108 kidney events and 70 composite outcomes occurred. The model effectively predicted adverse outcomes across CKD causes, further stratifying risk within cardiovascular‐kidney‐metabolic stage classifications. Conclusions: Circulating small extracellular vesicle‐derived miRNA profiles enable a noninvasive, longitudinally predictive model for adverse kidney and cardiovascular outcomes in CKD . This approach may improve early risk identification and clinical decision‐making.
- Open Access
- 16 December 2025
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 30 (2) , 198-210
Circulating small extracellular vesicles in chronic kidney disease and vascular calcification: “Tiny packages with big biological mission”
Chronic kidney disease (CKD), a condition affecting over 850 million people worldwide, is a major global health issue. CKD leads to multimorbidities and disease complexity, expediting the aging process and increasing mortality rates—a phenomenon sometimes referred to as “renal senescence.” The leading cause of death in patients with CKD is cardiovascular disease (CVD), accounting for one-third to one-half of all deaths, in stark contrast to cancer, which is the primary cause of death in the general population. While previous studies on kidney disease have focused extensively on urinary extracellular vesicles due to their potential as non-invasive diagnostic tools and their origin from kidney cells, our research highlighs the significance of circulating small extracellular vesicles (cEVs). We demonstrated that cEVs act as key mediators in the pathological intercellular and inter-organ communication between the kidneys and vascular smooth muscle cells (VSMCs). However, the biogenesis, cargo, and biological functions of cEVs remain incompletely understood under physiological and pathological conditions, including CKD. We identified microRNA (miRNA) transcriptomic signatures encapsulated in cEVs from CKD animal models, which were validated in human CKD samples. Notably, the depletion of specific miRNAs in CKD-derived cEVs promoted osteogenic differentiation of VSMCs and the deposition of calcium-phosphate crystals in vessels. In contrast, miRNAs enriched in cEVs from healthy individuals suppress these pathological processes, acting as a safeguard. These findings and future research could pave the way for the development of diagnostic and therapeutic platforms leveraging cEVs in nephrology. Graphical Abstract
- 16 December 2025
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 30 (2) , 198-210
Open AccessCirculating small extracellular vesicles in chronic kidney disease and vascular calcification: “Tiny packages with big biological mission”
Chronic kidney disease (CKD), a condition affecting over 850 million people worldwide, is a major global health issue. CKD leads to multimorbidities and disease complexity, expediting the aging process and increasing mortality rates—a phenomenon sometimes referred to as “renal senescence.” The leading cause of death in patients with CKD is cardiovascular disease (CVD), accounting for one-third to one-half of all deaths, in stark contrast to cancer, which is the primary cause of death in the general population. While previous studies on kidney disease have focused extensively on urinary extracellular vesicles due to their potential as non-invasive diagnostic tools and their origin from kidney cells, our research highlighs the significance of circulating small extracellular vesicles (cEVs). We demonstrated that cEVs act as key mediators in the pathological intercellular and inter-organ communication between the kidneys and vascular smooth muscle cells (VSMCs). However, the biogenesis, cargo, and biological functions of cEVs remain incompletely understood under physiological and pathological conditions, including CKD. We identified microRNA (miRNA) transcriptomic signatures encapsulated in cEVs from CKD animal models, which were validated in human CKD samples. Notably, the depletion of specific miRNAs in CKD-derived cEVs promoted osteogenic differentiation of VSMCs and the deposition of calcium-phosphate crystals in vessels. In contrast, miRNAs enriched in cEVs from healthy individuals suppress these pathological processes, acting as a safeguard. These findings and future research could pave the way for the development of diagnostic and therapeutic platforms leveraging cEVs in nephrology. Graphical Abstract
- Open Access
- 4 July 2025
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 5 (4) , oeaf096
Perioperative antihypertensive medications and effects on functional decline and mortality in non-cardiac surgery
Aims: The association between perioperative antihypertensive drugs and mortality as well as physical function in non-cardiac surgeries remains unclear. We aimed to clarify the association between six antihypertensive classes and postoperative outcomes. Methods and results: This observational cohort study involved adults undergoing non-cardiac surgeries between 2014 and 2019 using an administrative claims database. We recruited 408 810 patients who continuously used any class of antihypertensive medication both pre- and postoperatively and 2 190 064 non-continuous users aged ≥50 years who underwent five different types of non-cardiac surgeries. The risk for overall death or functional decline, defined as a ≥20% decrease in the Barthel Index score during hospitalization, was determined using multivariable logistic regression models. All-cause deaths or functional decline occurred in 4228 (1.0%) users and 17 978 (0.8%) non-users or 20 625 (5.0%) users and 66 218 (3.0%) non-users, respectively. Among single-class users, angiotensin-converting enzyme inhibitors (ACEis) or angiotensin II receptor blockers (ARBs) showed a multivariable odds ratio (OR) of 0.74 [95% confidence interval (CI) 0.62–0.89 vs. thiazide/thiazide-like diuretics (TH)] for the composite of mortality and functional decline. Among recipients of two medication classes, calcium receptor blockers (CCBs)/ACEi or ARB usage was associated with the lowest risk for composite outcome (OR, 0.86; 95% CI, 0.81–0.91 vs. TH/CCBs). The combinations of the ≥3 classes, including TH/CCB/ACEi or ARB, displayed the lowest odds for the composite outcome. In orthopaedic surgery and gastrointestinal resection, ACEis or ARBs were associated with better survival and physical function. Conclusion: Perioperative use of ACEis or ARBs is associated with favourable outcomes in non-cardiac surgeries.
- 4 July 2025
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 5 (4) , oeaf096
Open AccessPerioperative antihypertensive medications and effects on functional decline and mortality in non-cardiac surgery
Aims: The association between perioperative antihypertensive drugs and mortality as well as physical function in non-cardiac surgeries remains unclear. We aimed to clarify the association between six antihypertensive classes and postoperative outcomes. Methods and results: This observational cohort study involved adults undergoing non-cardiac surgeries between 2014 and 2019 using an administrative claims database. We recruited 408 810 patients who continuously used any class of antihypertensive medication both pre- and postoperatively and 2 190 064 non-continuous users aged ≥50 years who underwent five different types of non-cardiac surgeries. The risk for overall death or functional decline, defined as a ≥20% decrease in the Barthel Index score during hospitalization, was determined using multivariable logistic regression models. All-cause deaths or functional decline occurred in 4228 (1.0%) users and 17 978 (0.8%) non-users or 20 625 (5.0%) users and 66 218 (3.0%) non-users, respectively. Among single-class users, angiotensin-converting enzyme inhibitors (ACEis) or angiotensin II receptor blockers (ARBs) showed a multivariable odds ratio (OR) of 0.74 [95% confidence interval (CI) 0.62–0.89 vs. thiazide/thiazide-like diuretics (TH)] for the composite of mortality and functional decline. Among recipients of two medication classes, calcium receptor blockers (CCBs)/ACEi or ARB usage was associated with the lowest risk for composite outcome (OR, 0.86; 95% CI, 0.81–0.91 vs. TH/CCBs). The combinations of the ≥3 classes, including TH/CCB/ACEi or ARB, displayed the lowest odds for the composite outcome. In orthopaedic surgery and gastrointestinal resection, ACEis or ARBs were associated with better survival and physical function. Conclusion: Perioperative use of ACEis or ARBs is associated with favourable outcomes in non-cardiac surgeries.
- 28 May 2025
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 35 (6) , 796-798
Author's Reply: “Associations Between Dietary Potassium Intake From Different Food Sources and Hyperkalemia in Patients With Chronic Kidney Disease”
- 28 May 2025
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 35 (6) , 796-798
Author's Reply: “Associations Between Dietary Potassium Intake From Different Food Sources and Hyperkalemia in Patients With Chronic Kidney Disease”
- Open Access
- 17 April 2025
- Published by Elsevier in Kidney International Reports
- Vol. 10 (7) , 2424-2435
Cognitive Impairment and Physical Dysfunction Associated With Unplanned Dialysis Initiation
- 17 April 2025
- Published by Elsevier in Kidney International Reports
- Vol. 10 (7) , 2424-2435
Open AccessCognitive Impairment and Physical Dysfunction Associated With Unplanned Dialysis Initiation
- 17 March 2025
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 35 (4) , 560-561
Response Letter to Comment on: The Effect of Antihypertensive Therapy on Skeletal Muscle Mass and Bone Mineral Density in Patients With End-Stage Kidney Disease
- 17 March 2025
- Published by Elsevier in Journal of Renal Nutrition
- Vol. 35 (4) , 560-561
Response Letter to Comment on: The Effect of Antihypertensive Therapy on Skeletal Muscle Mass and Bone Mineral Density in Patients With End-Stage Kidney Disease
- 27 November 2024
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 38 (2) , 503-510
Nationwide mortality following acute type B aortic dissection and the survival advantage of obesity among dialysis patients in Japan
Background: The incidence of acute type B aortic dissection is higher than that of acute type A aortic dissection among patients on dialysis. However, the impact of being on chronic dialysis on outcomes after type B aortic dissection remains unknown. This study aimed to investigate the trends in in-hospital mortality after type B aortic dissection and the association between body mass index (BMI) and survival paradox on dialysis. Methods: This study included 48,889 type B aortic dissection hospitalizations in Japan from 2010 to 2020 based on data from a nationwide administrative database. Logistic regression was used to examine mortality risks and restricted cubic spline to investigate the non-linear association between mortality and BMI. Results: There were 2,116 in-hospital deaths, and the mortality rates were 8.0% in patients receiving chronic dialysis and 4.3% in patients not receiving dialysis. Patients not receiving dialysis had decreased trends of absolute mortality. Meanwhile, patients receiving chronic dialysis had a higher mortality rate from 2010 to 2020. The mortality risk was high in patients receiving chronic dialysis who were underweight and had normal BMI, but not in those who were overweight. Restricted cubic spline analysis showed that a higher BMI was associated with a lower mortality risk in dialysis patients. This finding contrasted the U-shape observed in patients not receiving dialysis. Conclusions: A lower BMI was associated with a higher risk of in-hospital mortality after type B aortic dissection among dialysis patients, thereby illustrating the obesity paradox. Our findings provide insights that can enhance the management strategies for dialysis patients facing type B aortic dissection. Graphical
- 27 November 2024
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 38 (2) , 503-510
Nationwide mortality following acute type B aortic dissection and the survival advantage of obesity among dialysis patients in Japan
Background: The incidence of acute type B aortic dissection is higher than that of acute type A aortic dissection among patients on dialysis. However, the impact of being on chronic dialysis on outcomes after type B aortic dissection remains unknown. This study aimed to investigate the trends in in-hospital mortality after type B aortic dissection and the association between body mass index (BMI) and survival paradox on dialysis. Methods: This study included 48,889 type B aortic dissection hospitalizations in Japan from 2010 to 2020 based on data from a nationwide administrative database. Logistic regression was used to examine mortality risks and restricted cubic spline to investigate the non-linear association between mortality and BMI. Results: There were 2,116 in-hospital deaths, and the mortality rates were 8.0% in patients receiving chronic dialysis and 4.3% in patients not receiving dialysis. Patients not receiving dialysis had decreased trends of absolute mortality. Meanwhile, patients receiving chronic dialysis had a higher mortality rate from 2010 to 2020. The mortality risk was high in patients receiving chronic dialysis who were underweight and had normal BMI, but not in those who were overweight. Restricted cubic spline analysis showed that a higher BMI was associated with a lower mortality risk in dialysis patients. This finding contrasted the U-shape observed in patients not receiving dialysis. Conclusions: A lower BMI was associated with a higher risk of in-hospital mortality after type B aortic dissection among dialysis patients, thereby illustrating the obesity paradox. Our findings provide insights that can enhance the management strategies for dialysis patients facing type B aortic dissection. Graphical